(Q35766117)
Statements
1 reference
Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence (English)
1 reference
Alessandra Ferrajoli
1 reference
Stefan Faderl
1 reference
William Wierda
1 reference
Susan O'Brien
1 reference
Michael J Keating
1 reference
Susan Lerner
1 reference
1 May 2010
1 reference
1 reference
116
1 reference
10
1 reference
2360-2365
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference